Multiple sclerosis drugs market to reach $61.43 billion by 2030 at 13.0% cagr, driven by strong support from government and non-government organizations funding research and treatment programs.
Read More
Medical device clinical trials market to reach $25.35 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic diseases.
Read More
Medical amino acid market to reach $5.99 billion by 2030 at 7.8% CAGR, driven by rising incidence of liver diseases.
Read More
Multiple myeloma drugs market to reach $31.61 billion by 2030 at 6.7% cagr, driven by increasing prevalence of hematological cancer and growing demand for effective targeted therapies.
Read More
Mastocytosis drug market to reach $1.84 billion by 2030 at 9.4% CAGR, driven by increasing investment in rare diseases.
Read More
Multidrug resistant bacteria market to reach $18.77 billion by 2030 at 7.4% cagr, driven by increasing prevalence of infectious diseases.
Read More
Mass spectrometry imaging market to reach $4.43 billion by 2030 at 9.0% CAGR, driven by rising demand for personalized medicine.
Read More
Mucolipidosis ii market to reach $16.19 billion by 2030 at 3.5% CAGR, driven by rise in gene therapy, increased research and development activities, and growing number of clinical trials.
Read More
Mantle cell lymphoma therapeutics market to reach $3.81 billion by 2030 at 8.1% CAGR, driven by rise in prevalence of mantle cell lymphoma.
Read More
Mtor inhibitors market to reach $10.39 billion by 2030 at 6.2% CAGR, driven by rise in prevalence of kidney diseases.
Read More